Related Experiment Video
Updated: Jul 10, 2026

10:13
Assessment of Age-related Changes in Cognitive Functions Using EmoCogMeter, a Novel Tablet-computer Based Approach
Published on: February 14, 2014
New computer-based cognitive function test for the elderly
1Dept. of Biomedical Engineering, Chiba University, Japan. tamurat@faculty.chiba-u.ac.jp
Summary
A new digital trail-making test effectively screens for Alzheimer's disease and dementia. Faster completion times correlate with higher cognitive function, indicating its potential as an early diagnostic tool.
Area of Science:
- Neurology
- Geriatrics
- Cognitive Science
Background:
- Dementia diagnosis relies on cognitive assessments.
- Early detection of Alzheimer's disease (AD) and cerebrovascular dementia (CVD) is crucial for timely intervention.
- Traditional screening tools may have limitations in accessibility or specificity.
Purpose of the Study:
- To develop and validate a modified, computer-based trail-making test (TMT) for dementia screening.
- To compare the performance of the digital TMT with the Mini-Mental State Examination (MMSE).
- To assess the digital TMT's utility in identifying cognitive deficits associated with AD and CVD.
Main Methods:
- A modified TMT was created using a PC and touch-panel display.
- Participants were instructed to touch numbers 1 through 36 sequentially as quickly as possible.
- The study included 134 dementia patients; 62 completed the digital TMT and MMSE.
Main Results:
- A significant negative correlation (r = -0.534) was found between digital TMT completion time and MMSE scores.
- Shorter TMT completion times were associated with better cognitive performance as measured by MMSE.
- The digital TMT demonstrated potential as an indicator of focal frontal lobe dysfunction.
Conclusions:
- The PC-based TMT is a viable tool for early screening of dementia, including Alzheimer's disease.
- This digital test offers a potentially sensitive and accessible method for cognitive assessment.
- The TMT may aid in differentiating cognitive impairments and identifying early-stage neurological changes.

